SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is experiencing heightened attention following a significant positive development: competitor Aquestive Therapeutics received an FDA deficiency letter for its Anaphylm application, reinforcing Neffy's position as the primary needle-free epinephrine treatment. This favorable news, alongside a recent market approval in China, is driving strong community sentiment focused on a potential short squeeze, given the considerable short interest. Investors are keenly observing Neffy's expanding global footprint and its ongoing exploration into additional indications like hives treatment.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is trending following news that a major investor acquired a 91% stake, sparking widespread speculation about a potential delisting or privatization to reduce operational costs. This significant ownership concentration has ignited intense community debate, with many discussing the potential for a monumental short squeeze, while others caution about risks like dilution or market correction as traders weigh holding over the long weekend.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant market pressure and extreme volatility following recent analyst downgrades and intensified fears surrounding AI competition from both new entrants and evolving general AI tools. While some in the community express concern over potential obsolescence, many view the steep sell-off as an irrational market overreaction, highlighting the company's strong fundamentals and ongoing AI integration efforts as a unique buying opportunity amidst a broader re-evaluation of the software sector.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

The community is buzzing around Applovin's recent sharp decline, with many attributing it to "max pain" options manipulation and broader software sector weakness, despite multiple analyst upgrades and strong growth prospects for its AI-powered Axon Ads platform. This divergence is fueling active debate among traders, with some seeing a prime dip-buying opportunity while others warn of perceived overvaluation and potential regulatory risks. Traders are closely watching for a rebound, especially with upcoming earnings reports on the horizon.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is surging following its selection as a prime contract awardee for a U.S. Missile Defense Agency program, which bulls see as a significant validation of its direct-to-device satellite technology. The community is buzzing with excitement over potential new revenue streams and the company's "first-mover" position, while some remain cautious, highlighting the speculative nature of the announcement and the company's current lack of operational revenue.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending as the community eagerly anticipates its Super App launch and discusses recent integrations, including a notable partnership with World Liberty Finance for on-chain payroll and card services. Investors are highlighting its robust ISO 20022 and MiCA compliance, positioning it as an undervalued utility project with significant long-term growth potential in real-world payments.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending as it continues to hit multi-year lows, fueling widespread investor frustration and intense criticism directed at CEO Jeff Green for the stock's persistent decline. Despite arguments for strong company fundamentals and a robust position in the open internet ad tech sector, the community is sharply divided between those calling for a bottom and others bracing for further drops.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma ($FIG) is experiencing significant downward pressure, with community discussions largely centered on concerns about upcoming insider lock-up expirations potentially leading to further share sales. While many investors express frustration and call it a "scam IPO" or "dead money," others view the current valuation as an attractive buying opportunity, confident in Figma's strong product adoption and leadership in collaborative design. The potential impact of AI, both as a threat to existing workflows and an integration opportunity, also fuels ongoing debate about the company's future.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is seeing heightened discussion following a significant drop in New York's online sports betting revenue, leading to community speculation about competitive pressures from prediction markets. Adding to the volatility, the NCAA is pushing for a federal halt on college sports betting amidst integrity concerns, casting a shadow of regulatory uncertainty over a key market segment. These factors are fueling debate among investors, balancing immediate challenges against longer-term growth prospects.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is experiencing significant bullish momentum, fueled by recent analyst upgrades and a new share buyback program. The community is actively discussing the company's expanding Small Modular Reactor (SMR) pipeline and securing substantial defense contracts globally, alongside its strong performance in civil aerospace. Investors are anticipating robust February earnings and highlighting the CEO's leadership in transforming the business.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CDTX $SLS $SMMT SLS GPS and SLS009 will tackle 40+ cancer types and peek sales of $40 Billion plus by 2030. ✌️🙏❤️‍🩹

Tony M

Cameron Drum

Ahmed Rodriguez

Mathew

Mateo

Barbaro69

Michael Baker

William Birkin

CMSP

$SLS $SMMT $CDTX    upper channel gap at $21.00+ from 2020/2021 and set a base there before BO PR hits the wires= $120.00+ News will hit in waves now. Market is waking up to the reality of what’s happening here is not one ☝️ but 2 Cancer platforms that will tackle up to 40+ cancer types and dethrone Keytruda is # 1 selling drug on the planet. 

My Weekend DD points me to first run like SMMT and than Finish with a CDTX type bidding war with 6 or more bidders and ultimate suitor walks away with $200.00+. Right now the move is towards the first base. I expect a PR and Change of control filing along with major option grants for the Sellas Top executives in the coming hours and days ahead. 
J.P Morgan health conference in SF is matter of days away and Sellas will be in the spotlight that concludes in a  bidding war. Big Institutional funds are gobbling up all the loose shares from the weak hands before change of control. 3 year plus GPS Maintenance worth billion upon billions. ✌️🙏❤️‍🩹

StockTwits for iOS

SELLAS Life Sciences Group Inc

Summit Therapeutics Inc

Cidara Therapeutics Inc

$CDTX $SLS $SMMT SLS PPS breaks $5.00, Next up $7.50 without news. ✌️🙏

 SLS GPS and SLS009 will tackle 40+ cancer types and peek sales of $40 Billion plus by 2030. ✌️🙏❤️‍🩹